Volume 10 - Special Issue                   J. Pediatr. Rev 2022, 10 - Special Issue: 363-366 | Back to browse issues page

XML Print

Molecular and Cell Biology Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran. , javadneg@yahoo.com
Abstract:   (2096 Views)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus disease that is highly contagious and affects all age groups of children. The incubation period of Coronavirus disease (COVID-19) ranges from 2 to 14 days. Diagnosis of COVID-19 is made by conducting nasal and pharyngeal swabs and analyzing sputum, stool, and blood samples for COVID-19 nucleic acid using reverse-transcription polymerase chain reaction (RT-PCR). A nasal swab is more sensitive and specific than a pharyngeal swab. Lung CT imaging is a confirmation and complimentary method which is more sensitive than RT-PCR analysis. The mortality rate of COVID-19 infection is very low in children. Treatment of COVID-19 is supportive care and home isolation for 2 weeks (1). The disease has now spread to most countries. Clinical manifestations of COVID-19 vary from asymptomatic to a severe form in children (2). 
Full-Text [PDF 307 kb]   (1112 Downloads) |   |   Full-Text (HTML)  (294 Views)  
Type of Study: Letter to the Editor | Subject: Infectious Diseases
Received: 2021/03/7 | Accepted: 2021/03/7 | Published: 2022/01/1

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.